Glucose Lowering Medications Flashcards
This drug class ends with “glitazone”
Thiazolidinediones
Drugs ending with “gliptin” are called
Dipeptidyl Peptidase 4(DPP-4) inhibitors
“Glifozin” are in this drug class
Sodium-Glucose Cotransporter 2(SGLT2) Inhibitors
Drug ending “dronate” belongs to this class
Bisphosphonate
Hemolytic anemia, hepatotoxicity and disulfiram reaction are rare ADRs for this drug class
a.Sulfonylureas
b.Bisphosphates
c.Synthetic Thyroxine
d.Biguanides
Sulfonylureas
This drug’s MOA includes stimulating insulin release from pancreatic beta cells
a. Rosiglitazone
b.Glipizide
c.Canagliflozin
d.semaglutide
Glipizide
Major contraindication is the concurrent use of gemfibrozil, which drug does this refer to
a.Prandin
b.Amaryl
c.Glucotrol
d.Fosamax
Prandin
Lactic acidosis is associated with which of the following
a.Metformin
b.Pioglitazone
c.Sitagliptin
d.Canaglifozin
Metformin
Major contraindications of DKA and T1DM are associated with which of the following:
Selecta all that apply
a.Repaglinide
b.linagliptin
c.Rosiglitazone
d.Glipizide
Repaglinide
Glipizide
Linagliptin
Key counseling point: Alcohol should be avoided while taking .
a.glimeperide
b.liraglutide
c.tresiba
d.dapagliflozin
Glimeperide
This drug primarily decreases glucose output from the liver and increases peripheral muscle glucose sensitivity as a secondary action
a.metformin
b.pioglitazone
c.saxagliptin
d.canagliflozin
Metformin
Congestive heart failure is a black box warning for which of the following
a.rosiglitazone
b.metformin
c.linagliptin
d.dulaglutide
Rosiglitazone
This drug can increase the risk of thyroid c-cells tumors
a.liraglutide
b.Insulin glargine
c.dapagliflozin
d.sitagliptin
liraglutide
This drug promotes cellular uptake of glucose, fatty acids and amino acids and their conversion to glycogen, triglycerides and proteins
a. Basaglar
b. Trulicity
c. Exenatide
d.Invokana
Basaglar
Pancreatitis, gallbladder disease,AKI are rare ADRS associated with this drug
a.Dulaglutide
b.Metformin
c.Pioglitazone
d.Tresiba
Dulaglutide
You want to tell patients to inject this drug SQ and rotate injection site each week, the GI side effects should improve overtime
a. Semaglutide
b.Insulin glargline
c.Dapagliflozin
d.Saxagliptin
Semaglutide
Severe renal impairment is majorly contraindicated with this drug
a.Invokana
b.Saxenda
c.Tradjenta
d.Avandia
Invokana
Chest pain, ischemia and hypersensitivity are rare ADRs of this drug
a.Repaglinide
b.Glimepiride
c.Pioglitazone
d.Semaglutide
Repaglinide
Whilst on this drug patients should take it once daily (in the morning) and stay hydrated whilst taking it
a.Ozempic
b.Farxiga
c.Onglyza
d.Avandia
Farxiga
If a person has a family history of medullary thyroid carcinoma (MTC)and multiple endocrine neoplasia syndrome type 2(MEN2)they are at increased risk for reactions with this drug
a.Toujeo
b.Ozempic
c.Canagliflozin
d.Saxagliptin
Ozempic
With this drug you want to tell patients to monitor for weight gain and swelling of legs
a. Repaglinide
b.Glucophage
c.Rosiglitazone
d.Glipizide
Rosiglitazone
eGFR<30mL/min, metabolic acidosis, use with contrast media
a.Avandia
b.Januvia
c.Glucophage
d.Farxiga
Glucophage
Reactions include hypotension, UTI, yeast infection, bone fracture, perineal necrotizing fasciitis
a.Exenatide
b.Dulaglutide
c.Canagliflozin
d.Lantus
Canagliflozin
Tell patient to take this drug with food to avoid GI upset
a.Basaglar
b.Ozempic
c.Glucophage
d.linagliptin
Glucophage